More than 150 representatives and observers from organizations were on the tarmac at Dulles International Airport on June 25 ...

Over the past decade, several novel immunotherapies have transformed the treatment landscape of relapsed or refractory B-cell acute lymphoblastic leukaemia. In the pivotal TOWER trial, blinatumomab—a ...